| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.0003 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |